期刊文献+

非何杰金淋巴瘤110例死亡病例分析 被引量:3

DEATH IN 110 NON-HODGKIN'S LYMPHOMA(NHL) PATIENTS
原文传递
导出
摘要 1983年至1986年我院共收治NHL324例,随访到1989年6月,110例死亡,其中临床Ⅰ期8例,Ⅱ期17例,19例疗中由ⅠⅡ期进展为Ⅲ、Ⅳ期,Ⅲ期17例,Ⅳ期49例.50例伴有全身症状.ⅠⅡ期以局部扩大野放疗为主,部分病例做腹部预防照射。Ⅲ Ⅳ期以化疗为主。分析ⅠⅡ期疗失败的原因:Ⅰ.临床表现为高度进展性,2.早期播散倾向,3.原发于韦氏环的病例、腹部预防照射仅能预防腹腔复发,仍可出现腹腔以外部位复发,4.个别病例表现为放射抗拒性.Ⅲ、Ⅳ期治疗失败的原因与治疗毒性反应和没能使用较强的化疗方案有关。 From 1983 to 1986,324 NHL patients were treated and followed to June 1989. Stage Ⅰ and Ⅱlesions were treated with extended field irradiation (EFT) and stage Ⅲ and Ⅳ lesions were chiefly treated with chemotherapy. 110 patients have died during follow-up. Cause of failure in Stage Ⅰ and Ⅱ patients were: 1. Highly progressive disease, 2. Early disseminating tendency, 3. For NHL in the Waldeyer's ring, abdominal prophylactic irradiation did prevent intra-abdominal recurrence but extra-abdominal recrudescence may still occur,and 4. Some lesions were radio-ressJstant. Toxicity of drugs and conservative chemotherapy were related to failure in Stage Ⅲ and Ⅳ lesions.
出处 《中华放射肿瘤学杂志》 CSCD 1992年第1期32-35,68-69,共6页 Chinese Journal of Radiation Oncology
  • 相关文献

参考文献8

  • 1Kaminski MS,et el.Factors predicting survival in adults with stageⅠand Ⅱ large-cell lymphoma treated with primary radiation therapy. Annals of Internal Medicine . 1986
  • 2Bejetta E,et al.Combined chemotherapy (cvp rs BAcop)radiotherapy in PS ⅠⅡ diffuse non-Hodgkin’s lymphomas. Proceedings of the American Society of Clinical Oncology . 1983
  • 3Hellman S,et al.The place of radiation therapy in the treat-#ment of non-Hodgkin’s Lymphomas. Cancer . 1977
  • 4Manfardini S,et al.Improved five year survival after combined radiotherapy-chemotherapy for stage Ⅰ-Ⅱ non-Hodgkin’s lymphoma. International Journal of Radiation Oncology Biology Physics . 1980
  • 5Miller TP,et al.Initial chemotherapy for clinically localized lymphomas of unfavorable histology. Blood . 1983
  • 6Hrynuik W,et al.The importance of dose intensity in chemotherapy of metastatic breast cancer. Journal of Clinical Oncology . 1984
  • 7March P,et al.Improved survival following combined radiation therapy and chemotherapy for unfavorable prognosis stage Ⅰ,and Ⅱ non-Hodgkin’s lymphomas. Journal of Clinical Oncology . 1985
  • 8Goldie JH,et al.The genetic origin of drug resistance in neoplasms: implications for systomic therapy. Cancer Research . 1984

同被引文献8

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部